DK0506434T3 - Thiazolidinon- og oxazolidinon-derivater, fremstilling deraf og deres anvendelse som vasodilaterende midler - Google Patents

Thiazolidinon- og oxazolidinon-derivater, fremstilling deraf og deres anvendelse som vasodilaterende midler

Info

Publication number
DK0506434T3
DK0506434T3 DK92302674.4T DK92302674T DK0506434T3 DK 0506434 T3 DK0506434 T3 DK 0506434T3 DK 92302674 T DK92302674 T DK 92302674T DK 0506434 T3 DK0506434 T3 DK 0506434T3
Authority
DK
Denmark
Prior art keywords
thiazolidinone
vasodilators
preparation
aralkyl
alkyl
Prior art date
Application number
DK92302674.4T
Other languages
English (en)
Inventor
Hiroyuki Koike
Sadao Ishihara
Fujio Saito
Takao Yoshioka
Sigeki Miyake
Hiroshi Mizuno
Original Assignee
Sankyo Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sankyo Co filed Critical Sankyo Co
Application granted granted Critical
Publication of DK0506434T3 publication Critical patent/DK0506434T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/08—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D263/16—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D263/18—Oxygen atoms
    • C07D263/20—Oxygen atoms attached in position 2
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/08—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D263/16—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D263/18—Oxygen atoms
    • C07D263/20—Oxygen atoms attached in position 2
    • C07D263/24—Oxygen atoms attached in position 2 with hydrocarbon radicals, substituted by oxygen atoms, attached to other ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/08—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D277/12—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/14—Oxygen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Cardiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Pyrrole Compounds (AREA)
  • Indole Compounds (AREA)
  • Silver Salt Photography Or Processing Solution Therefor (AREA)
  • Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)
  • Emulsifying, Dispersing, Foam-Producing Or Wetting Agents (AREA)
DK92302674.4T 1991-03-27 1992-03-27 Thiazolidinon- og oxazolidinon-derivater, fremstilling deraf og deres anvendelse som vasodilaterende midler DK0506434T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP6308891 1991-03-27
JP10275191 1991-05-08
JP33030491 1991-12-13

Publications (1)

Publication Number Publication Date
DK0506434T3 true DK0506434T3 (da) 1995-07-24

Family

ID=27298042

Family Applications (1)

Application Number Title Priority Date Filing Date
DK92302674.4T DK0506434T3 (da) 1991-03-27 1992-03-27 Thiazolidinon- og oxazolidinon-derivater, fremstilling deraf og deres anvendelse som vasodilaterende midler

Country Status (23)

Country Link
US (2) US5298516A (da)
EP (1) EP0506434B1 (da)
JP (1) JPH0780859B2 (da)
KR (1) KR0152097B1 (da)
CN (2) CN1031824C (da)
AT (1) ATE118770T1 (da)
AU (1) AU647599B2 (da)
CA (1) CA2064108C (da)
CZ (1) CZ282529B6 (da)
DE (1) DE69201451T2 (da)
DK (1) DK0506434T3 (da)
ES (1) ES2072095T3 (da)
FI (1) FI106260B (da)
HK (1) HK123595A (da)
HU (2) HU217969B (da)
IE (1) IE67383B1 (da)
IL (1) IL101395A (da)
IS (1) IS1746B (da)
NO (1) NO304311B1 (da)
NZ (1) NZ242154A (da)
PH (1) PH30493A (da)
RU (1) RU2055073C1 (da)
TW (1) TW226015B (da)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3454531B2 (ja) * 1991-11-07 2003-10-06 三共株式会社 ニトロキシアルキルアミド誘導体
CA2158368A1 (en) * 1993-03-15 1994-09-29 Jan Bron Use of substituted alkyl nitrates for the treatment of pathologically raised intraocular pressure
DE4429461A1 (de) * 1994-08-19 1996-02-22 Merck Patent Gmbh Adhäsionsrezeptor-Antagonisten
MX9704435A (es) * 1994-12-15 1997-10-31 Sankyio Company Ltd Compuestos de tiazolidinona y agente terapeutico o agente de prevencion para angina de pecho, que comprende los compuestos como un ingrediente activo.
HU223094B1 (hu) * 1995-03-02 2004-03-29 Sankyo Co., Ltd. Optikailag aktív tiazolidinonszármazékok, előállításuk, a vegyületeket hatóanyagként tartalmazó gyógyászati készítmények és tia-vagy oxazolidinonszármazékok alkalmazása gyógyászati készítmények előállítására
US5925658A (en) * 1995-03-02 1999-07-20 Sankyo Company, Limited Optically active thiazolidinone derivative
WO1997000239A1 (fr) * 1995-06-14 1997-01-03 Sankyo Company, Limited Medicament contre l'angine contenant un derive nitroxy comme ingredient actif
BE1010768A3 (nl) * 1996-11-26 1999-01-05 Dsm Nv Een werkwijze voor de bereiding van alpha-aminozuuramiden, alpha-aminozuren en derivaten ervan.
IL120531A (en) 1997-03-26 2006-12-31 Yissum Res Dev Co Nitric oxide donors and pharmaceutical compositions containing them
WO2002069967A1 (fr) * 2001-03-01 2002-09-12 Sankyo Company, Limited Compositions a absorption percutanee
CA2842106A1 (en) * 2011-07-28 2013-01-31 Promentis Pharmaceuticals, Inc. Cysteine prodrugs
US10239847B1 (en) 2016-03-03 2019-03-26 Cellactin Method for 2-oxothiazolidine-4-carboxylic acid for cellular glutathione

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4200640A (en) * 1976-04-02 1980-04-29 Chugai Seiyaku Kabushiki Kaisha Nitric ester of N-(2-hydroxyethyl)nicotinamide and pharmaceutical use
GB8717068D0 (en) * 1987-07-20 1987-08-26 Fujisawa Pharmaceutical Co Nitric ester derivative
DE10199034I2 (de) * 1989-04-21 2011-07-21 Ei Du Pont Du Nemours & Co Fungizide oxazolidinone.

Also Published As

Publication number Publication date
IE920966A1 (en) 1992-10-07
RU2055073C1 (ru) 1996-02-27
CZ282529B6 (cs) 1997-08-13
HK123595A (en) 1995-08-04
HU9201033D0 (en) 1992-06-29
ES2072095T3 (es) 1995-07-01
IL101395A (en) 1996-10-16
CN1066067A (zh) 1992-11-11
IE67383B1 (en) 1996-03-20
CN1113435A (zh) 1995-12-20
FI921340A (fi) 1992-09-28
CZ91692A3 (en) 1993-01-13
CN1031824C (zh) 1996-05-22
DE69201451D1 (de) 1995-03-30
IL101395A0 (en) 1992-11-15
CA2064108A1 (en) 1992-09-28
FI921340A0 (fi) 1992-03-26
HU211969A9 (en) 1996-01-29
DE69201451T2 (de) 1995-10-12
NO921159D0 (no) 1992-03-25
HU217969B (hu) 2000-05-28
ATE118770T1 (de) 1995-03-15
US5356918A (en) 1994-10-18
FI106260B (fi) 2000-12-29
KR920018036A (ko) 1992-10-21
NZ242154A (en) 1993-09-27
KR0152097B1 (ko) 1998-10-15
HUT68242A (en) 1995-06-28
IS1746B (is) 2000-07-11
US5298516A (en) 1994-03-29
EP0506434B1 (en) 1995-02-22
AU647599B2 (en) 1994-03-24
PH30493A (en) 1997-05-28
IS3828A (is) 1992-09-28
CN1096265C (zh) 2002-12-18
CA2064108C (en) 2000-09-26
EP0506434A1 (en) 1992-09-30
NO304311B1 (no) 1998-11-30
JPH0780859B2 (ja) 1995-08-30
AU1312292A (en) 1992-10-01
TW226015B (da) 1994-07-01
NO921159L (no) 1992-09-28
JPH05213910A (ja) 1993-08-24

Similar Documents

Publication Publication Date Title
AU632163B2 (en) 10-(1-hydroxyethyl)-11-oxo-1-azatricyclo(7.2.0.03,8)undec-2- ene-2-carboxylic acid derivatives
DK0632036T3 (da) Amidderivater med antipypercholesteræmisk aktivitet, deres fremstilling og deres terapeutiske anvendelser
ATE161839T1 (de) 1-(2-(arylsulfonylamino)-1-oxoethyl>piperidin- derivate, ihre herstellung und therapeutische verwendung
DK0506434T3 (da) Thiazolidinon- og oxazolidinon-derivater, fremstilling deraf og deres anvendelse som vasodilaterende midler
DK0417790T3 (da) S-triazolo(3,4-i)purin-derivater
HUT75647A (en) Imidazolidinone derivatives and pharmaceutical compositions containing them, which are suitable for treament of senile dementia
HK1000494A1 (en) Thiazolidinone or oxazolidinone derivatives to treat angina pectoris or compositions containing the same as active ingredient
DK96086A (da) 8-thiotetrahydroquinolinderivater, deres fremstilling og anvendelse som laegemidler